Cargando…

Dysbiosis of human gut microbiome in young-onset colorectal cancer

The incidence of sporadic young-onset colorectal cancer (yCRC) is increasing. A significant knowledge gap exists in the gut microbiota and its diagnostic value for yCRC patients. Through 16S rRNA gene sequencing, 728 samples are collected to identify microbial markers, and an independent cohort of 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yongzhi, Du, Lutao, Shi, Debing, Kong, Cheng, Liu, Jianqiang, Liu, Guang, Li, Xinxiang, Ma, Yanlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604900/ https://www.ncbi.nlm.nih.gov/pubmed/34799562 http://dx.doi.org/10.1038/s41467-021-27112-y

Ejemplares similares

Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2020)

Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
por: Li, Jinming, et al.
Publicado: (2023)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
por: Singh, Samradhi, et al.
Publicado: (2023)

Dysbiosis of human tumor microbiome and aberrant residence of Actinomyces in tumor-associated fibroblasts in young-onset colorectal cancer
por: Xu, Zhuoqing, et al.
Publicado: (2022)

The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development
por: Genua, Flavia, et al.
Publicado: (2021)

Dysbiosis of skin microbiome and gut microbiome in melanoma progression
por: Mekadim, Chahrazed, et al.
Publicado: (2022)

N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
por: Li, Jinming, et al.
Publicado: (2021)

The Association of Microbiome Dysbiosis With Colorectal Cancer
por: Artemev, Artem, et al.
Publicado: (2022)

Current Perspectives on Gut Microbiome Dysbiosis and Depression
por: Capuco, Alexander, et al.
Publicado: (2020)

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2019)

SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
por: Howell, Mark C., et al.
Publicado: (2021)

The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review
por: Zhang, Xianzhuo, et al.
Publicado: (2023)

Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer
por: Ahmad Kendong, Siti Maryam, et al.
Publicado: (2021)

Preventive Effects and Mechanisms of Garlic on Dyslipidemia and Gut Microbiome Dysbiosis
por: Chen, Keyu, et al.
Publicado: (2019)

Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer
por: Liu, Fang, et al.
Publicado: (2019)

Metabolome of human gut microbiome is predictive of host dysbiosis
por: Larsen, Peter E., et al.
Publicado: (2015)

Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis
por: Xu, Zhiming, et al.
Publicado: (2020)

Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients
por: Swarte, J. Casper, et al.
Publicado: (2020)

2581. An Invertebrate Model to Study Gut Microbiome Dysbiosis
por: Alnezary, Faris S, et al.
Publicado: (2019)

Gut Microbiome Dysbiosis in Alcoholism: Consequences for Health and Recovery
por: Day, Andrew Whittier, et al.
Publicado: (2022)

Dysbiosis of the Gut Microbiome Is Associated With Histopathology of Lung Cancer
por: Qin, Xiong, et al.
Publicado: (2022)

Gut microbiome health and dysbiosis: A clinical primer
por: Bidell, Monique R., et al.
Publicado: (2022)

Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
por: Zhang, Weizheng, et al.
Publicado: (2023)

Serum Oxytocin Level Correlates With Gut Microbiome Dysbiosis in Children With Autism Spectrum Disorder
por: Huang, Minshi, et al.
Publicado: (2021)

Helicobacter pylori Infection Aggravates Dysbiosis of Gut Microbiome in Children With Gastritis
por: Yang, Lu, et al.
Publicado: (2019)

A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
por: Elbere, Ilze, et al.
Publicado: (2018)

Dysbiosis of the gut and lung microbiome has a role in asthma
por: Hufnagl, Karin, et al.
Publicado: (2020)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
por: Monteiro, Renato C., et al.
Publicado: (2022)

Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders
por: Elkafas, Hoda, et al.
Publicado: (2022)

Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia
por: Cheney, Alexandra M., et al.
Publicado: (2023)

Gut microbiome dysbiosis is associated with host genetics in the Norwegian Lundehund
por: Melis, Claudia, et al.
Publicado: (2023)

Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
por: Chattopadhyay, Indranil, et al.
Publicado: (2022)

Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis
por: Prasad, Ram, et al.
Publicado: (2022)

Dysbiosis of gut microbiota in promoting the development of colorectal cancer
por: Zou, Shaomin, et al.
Publicado: (2018)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
por: Belizário, José E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vk5oh98dvvsmhva6i9quv7oksi